Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus

Vesell, Elliot S ; Beyer, Karl H

Toxicology (Amsterdam), 2000-04, Vol.144 (1), p.5-11 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível